Repligen raises FY26 EPS view to $1.97-$2.05 from $1.93-$2.10, consensus $1.97

Cuts FY26 revenue view to $803M-$833M from $810M-$840M, consensus $827.74M. The company said, “We also continue to make meaningful progress on our strategic priorities. We launched a Transformation Office initiative and divested a non-core filtration business as we accelerate our focus on profitable growth. In addition, we entered into a new partnership in China, which represents an important step in advancing our APAC strategy. We remain committed to disciplined, intentional investment-expanding our commercial capabilities and optimizing our infrastructure to support scalable, sustainable growth in the years ahead.”